Category: Jurisdictions
-
Pfizer, BioNTech hit back against GSK mRNA suits in UPC, Ireland: file UK revocation action
The move does not come as a major surprise, given the pharma companies’ previous success against GlaxoSmithKline in the UK.
-
TP-Link’s UK lawsuit against Huawei appears uneconomical: widely accepted pool option and potential German blowback
TP-Link filed a UK lawsuit against Huawei, but the terms of the Sisvel WiFi 6 pool through which those patents are available have been widely accepted and German courts won’t let UK courts torpedo their cases.
-
Acer seeking counterleverage against Nokia through “threat letters” in U.S. despite highly asymmetric SEP portfolios and sales volumes: DJ action
Acer sent “threat letters” to U.S. telecommunications carriers using Nokia equipment, provoking a declaratory judgment complaint.
-
Oura escalates Ultrahuman patent dispute with more patents and accusations of editing Wikipedia page to accuse Oura of patent trolling
The patent dispute between smart-ring pioneer Oura and Ultrahuman is getting dirty, with Oura accusing Ultrahuman of having edited its Wikipedia page and impersonated its CEO.
-
Stanford retains cancer detection patents licensed to Foresight Diagnostics, but Roche gets non-exclusive license: settlement
Roche Molecular Systems, Stanford and Foresight Diagnostics have recently settled a dispute over trade secrets, breach of contract, unfair competition and patent ownership.
-
Post-judgment cleanup orders in UK pharma cases: no disgorgement of Bayer profits; Teva, Glenmark, Generics (UK) recover two thirds of costs
AstraZeneca must reimburse two thirds of the costs of an unsuccessful case Teva, Glenmark and Generics (UK). Separately, Bayer does not have to disgorge profits to Sandoz.
-
Judge dismisses Ultrahuman’s Indian countersuit against Oura for failure to disclose key information from ITC case: Ultrahuman must refile
Mrs. Justice Arora faults Ultrahuman for not disclosing ITC decisions that were relevant to the question of whether Ultrahuman’s Indian patent-in-suit is valid.
-
Federal Circuit revives Sonos v. Google: laches allowed in rare cases only
The Federal Circuit has partly reversed a judgment by the Northern District of California, finding that it abused its discretion in finding that Google was prejudiced by Sonos’ alleged delay in claiming the subject matter at issue via continuation practice.